Report Detail
Global Bovine Blood Plasma Derivatives Market Insights and Forecast to 2027
- RnM3302032 |
- 11 June, 2021 |
- Global |
- 149 Pages |
- QYResearch |
- Other
Bovine Blood Plasma Derivatives covers different types of bovine blood plasma derivatives,and typically used in scientific research and industrial production.
Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals and Bovogen are major players in this market. Relying on blood supply from around the world, Thermo Fisher, GE Healthcare and Merck (Sigma-Aldrich) are the world's three giants. In 2017, Merck (Sigma-Aldrich) is the world leader with a market share of 22.62%
Market Analysis and Insights: Global Bovine Blood Plasma Derivatives Market
The global Bovine Blood Plasma Derivatives market is valued at US$ 1847.4 million in 2019. The market size will reach US$ 2522.7 million by the end of 2026, growing at a CAGR of 4.5% during 2021-2026.
Global Bovine Blood Plasma Derivatives Scope and Segment
Bovine Blood Plasma Derivatives market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bovine Blood Plasma Derivatives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Bovine Serum
FBS
Bovine Serum Albumin
Fibrinogen
Protein Ingredient
Other
Segment by Application
Scientific Research
Industrial Production
Feed
Others
By Company
Thermo Fisher
GE Healthcare
Merck (Sigma-Aldrich)
Moregate BioTech
Gemini
Atlanta Biologicals
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
VWR
Corning
Serana
Lanzhou Minhai
Zhejiang Tianhang Biotechnology
ExCell Bio
Jin Yuan Kang
American Protein Company
Sonac
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
- 1.1 Bovine Blood Plasma Derivatives Product Introduction
- 1.2 Market by Type
- 1.2.1 Global Bovine Blood Plasma Derivatives Market Size Growth Rate by Type
- 1.2.2 Bovine Serum
- 1.2.3 FBS
- 1.2.4 Bovine Serum Albumin
- 1.2.5 Fibrinogen
- 1.2.6 Protein Ingredient
- 1.2.7 Other
- 1.3 Market by Application
- 1.3.1 Global Bovine Blood Plasma Derivatives Market Size Growth Rate by Application
- 1.3.2 Scientific Research
- 1.3.3 Industrial Production
- 1.3.4 Feed
- 1.3.5 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Bovine Blood Plasma Derivatives Production
- 2.1 Global Bovine Blood Plasma Derivatives Production Capacity (2016-2027)
- 2.2 Global Bovine Blood Plasma Derivatives Production by Region: 2016 VS 2021 VS 2027
- 2.3 Global Bovine Blood Plasma Derivatives Production by Region
- 2.3.1 Global Bovine Blood Plasma Derivatives Historic Production by Region (2016-2021)
- 2.3.2 Global Bovine Blood Plasma Derivatives Forecasted Production by Region (2022-2027)
- 2.4 North America
- 2.5 Europe
- 2.6 China
- 2.7 Japan
3 Global Bovine Blood Plasma Derivatives Sales in Volume & Value Estimates and Forecasts
- 3.1 Global Bovine Blood Plasma Derivatives Sales Estimates and Forecasts 2016-2027
- 3.2 Global Bovine Blood Plasma Derivatives Revenue Estimates and Forecasts 2016-2027
- 3.3 Global Bovine Blood Plasma Derivatives Revenue by Region: 2016 VS 2021 VS 2027
- 3.4 Global Top Bovine Blood Plasma Derivatives Regions by Sales
- 3.4.1 Global Top Bovine Blood Plasma Derivatives Regions by Sales (2016-2021)
- 3.4.2 Global Top Bovine Blood Plasma Derivatives Regions by Sales (2022-2027)
- 3.5 Global Top Bovine Blood Plasma Derivatives Regions by Revenue
- 3.5.1 Global Top Bovine Blood Plasma Derivatives Regions by Revenue (2016-2021)
- 3.5.2 Global Top Bovine Blood Plasma Derivatives Regions by Revenue (2022-2027)
- 3.6 North America
- 3.7 Europe
- 3.8 Asia-Pacific
- 3.9 Latin America
- 3.10 Middle East & Africa
4 Competition by Manufactures
- 4.1 Global Bovine Blood Plasma Derivatives Supply by Manufacturers
- 4.1.1 Global Top Bovine Blood Plasma Derivatives Manufacturers by Production Capacity (2020 VS 2021)
- 4.1.2 Global Top Bovine Blood Plasma Derivatives Manufacturers by Production (2016-2021)
- 4.2 Global Bovine Blood Plasma Derivatives Sales by Manufacturers
- 4.2.1 Global Top Bovine Blood Plasma Derivatives Manufacturers by Sales (2016-2021)
- 4.2.2 Global Top Bovine Blood Plasma Derivatives Manufacturers Market Share by Sales (2016-2021)
- 4.2.3 Global Top 10 and Top 5 Companies by Bovine Blood Plasma Derivatives Sales in 2020
- 4.3 Global Bovine Blood Plasma Derivatives Revenue by Manufacturers
- 4.3.1 Global Top Bovine Blood Plasma Derivatives Manufacturers by Revenue (2016-2021)
- 4.3.2 Global Top Bovine Blood Plasma Derivatives Manufacturers Market Share by Revenue (2016-2021)
- 4.3.3 Global Top 10 and Top 5 Companies by Bovine Blood Plasma Derivatives Revenue in 2020
- 4.4 Global Bovine Blood Plasma Derivatives Sales Price by Manufacturers
- 4.5 Analysis of Competitive Landscape
- 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 4.5.2 Global Bovine Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.5.3 Global Bovine Blood Plasma Derivatives Manufacturers Geographical Distribution
- 4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
- 5.1 Global Bovine Blood Plasma Derivatives Sales by Type
- 5.1.1 Global Bovine Blood Plasma Derivatives Historical Sales by Type (2016-2021)
- 5.1.2 Global Bovine Blood Plasma Derivatives Forecasted Sales by Type (2022-2027)
- 5.1.3 Global Bovine Blood Plasma Derivatives Sales Market Share by Type (2016-2027)
- 5.2 Global Bovine Blood Plasma Derivatives Revenue by Type
- 5.2.1 Global Bovine Blood Plasma Derivatives Historical Revenue by Type (2016-2021)
- 5.2.2 Global Bovine Blood Plasma Derivatives Forecasted Revenue by Type (2022-2027)
- 5.2.3 Global Bovine Blood Plasma Derivatives Revenue Market Share by Type (2016-2027)
- 5.3 Global Bovine Blood Plasma Derivatives Price by Type
- 5.3.1 Global Bovine Blood Plasma Derivatives Price by Type (2016-2021)
- 5.3.2 Global Bovine Blood Plasma Derivatives Price Forecast by Type (2022-2027)
6 Market Size by Application
- 6.1 Global Bovine Blood Plasma Derivatives Sales by Application
- 6.1.1 Global Bovine Blood Plasma Derivatives Historical Sales by Application (2016-2021)
- 6.1.2 Global Bovine Blood Plasma Derivatives Forecasted Sales by Application (2022-2027)
- 6.1.3 Global Bovine Blood Plasma Derivatives Sales Market Share by Application (2016-2027)
- 6.2 Global Bovine Blood Plasma Derivatives Revenue by Application
- 6.2.1 Global Bovine Blood Plasma Derivatives Historical Revenue by Application (2016-2021)
- 6.2.2 Global Bovine Blood Plasma Derivatives Forecasted Revenue by Application (2022-2027)
- 6.2.3 Global Bovine Blood Plasma Derivatives Revenue Market Share by Application (2016-2027)
- 6.3 Global Bovine Blood Plasma Derivatives Price by Application
- 6.3.1 Global Bovine Blood Plasma Derivatives Price by Application (2016-2021)
- 6.3.2 Global Bovine Blood Plasma Derivatives Price Forecast by Application (2022-2027)
7 North America
- 7.1 North America Bovine Blood Plasma Derivatives Market Size by Type
- 7.1.1 North America Bovine Blood Plasma Derivatives Sales by Type (2016-2027)
- 7.1.2 North America Bovine Blood Plasma Derivatives Revenue by Type (2016-2027)
- 7.2 North America Bovine Blood Plasma Derivatives Market Size by Application
- 7.2.1 North America Bovine Blood Plasma Derivatives Sales by Application (2016-2027)
- 7.2.2 North America Bovine Blood Plasma Derivatives Revenue by Application (2016-2027)
- 7.3 North America Bovine Blood Plasma Derivatives Sales by Country
- 7.3.1 North America Bovine Blood Plasma Derivatives Sales by Country (2016-2027)
- 7.3.2 North America Bovine Blood Plasma Derivatives Revenue by Country (2016-2027)
- 7.3.3 U.S.
- 7.3.4 Canada
8 Europe
- 8.1 Europe Bovine Blood Plasma Derivatives Market Size by Type
- 8.1.1 Europe Bovine Blood Plasma Derivatives Sales by Type (2016-2027)
- 8.1.2 Europe Bovine Blood Plasma Derivatives Revenue by Type (2016-2027)
- 8.2 Europe Bovine Blood Plasma Derivatives Market Size by Application
- 8.2.1 Europe Bovine Blood Plasma Derivatives Sales by Application (2016-2027)
- 8.2.2 Europe Bovine Blood Plasma Derivatives Revenue by Application (2016-2027)
- 8.3 Europe Bovine Blood Plasma Derivatives Sales by Country
- 8.3.1 Europe Bovine Blood Plasma Derivatives Sales by Country (2016-2027)
- 8.3.2 Europe Bovine Blood Plasma Derivatives Revenue by Country (2016-2027)
- 8.3.3 Germany
- 8.3.4 France
- 8.3.5 U.K.
- 8.3.6 Italy
- 8.3.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Bovine Blood Plasma Derivatives Market Size by Type
- 9.1.1 Asia Pacific Bovine Blood Plasma Derivatives Sales by Type (2016-2027)
- 9.1.2 Asia Pacific Bovine Blood Plasma Derivatives Revenue by Type (2016-2027)
- 9.2 Asia Pacific Bovine Blood Plasma Derivatives Market Size by Application
- 9.2.1 Asia Pacific Bovine Blood Plasma Derivatives Sales by Application (2016-2027)
- 9.2.2 Asia Pacific Bovine Blood Plasma Derivatives Revenue by Application (2016-2027)
- 9.3 Asia Pacific Bovine Blood Plasma Derivatives Sales by Region
- 9.3.1 Asia Pacific Bovine Blood Plasma Derivatives Sales by Region (2016-2027)
- 9.3.2 Asia Pacific Bovine Blood Plasma Derivatives Revenue by Region (2016-2027)
- 9.3.3 China
- 9.3.4 Japan
- 9.3.5 South Korea
- 9.3.6 India
- 9.3.7 Australia
- 9.3.8 Taiwan
- 9.3.9 Indonesia
- 9.3.10 Thailand
- 9.3.11 Malaysia
- 9.3.12 Philippines
10 Latin America
- 10.1 Latin America Bovine Blood Plasma Derivatives Market Size by Type
- 10.1.1 Latin America Bovine Blood Plasma Derivatives Sales by Type (2016-2027)
- 10.1.2 Latin America Bovine Blood Plasma Derivatives Revenue by Type (2016-2027)
- 10.2 Latin America Bovine Blood Plasma Derivatives Market Size by Application
- 10.2.1 Latin America Bovine Blood Plasma Derivatives Sales by Application (2016-2027)
- 10.2.2 Latin America Bovine Blood Plasma Derivatives Revenue by Application (2016-2027)
- 10.3 Latin America Bovine Blood Plasma Derivatives Sales by Country
- 10.3.1 Latin America Bovine Blood Plasma Derivatives Sales by Country (2016-2027)
- 10.3.2 Latin America Bovine Blood Plasma Derivatives Revenue by Country (2016-2027)
- 10.3.3 Mexico
- 10.3.4 Brazil
- 10.3.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Bovine Blood Plasma Derivatives Market Size by Type
- 11.1.1 Middle East and Africa Bovine Blood Plasma Derivatives Sales by Type (2016-2027)
- 11.1.2 Middle East and Africa Bovine Blood Plasma Derivatives Revenue by Type (2016-2027)
- 11.2 Middle East and Africa Bovine Blood Plasma Derivatives Market Size by Application
- 11.2.1 Middle East and Africa Bovine Blood Plasma Derivatives Sales by Application (2016-2027)
- 11.2.2 Middle East and Africa Bovine Blood Plasma Derivatives Revenue by Application (2016-2027)
- 11.3 Middle East and Africa Bovine Blood Plasma Derivatives Sales by Country
- 11.3.1 Middle East and Africa Bovine Blood Plasma Derivatives Sales by Country (2016-2027)
- 11.3.2 Middle East and Africa Bovine Blood Plasma Derivatives Revenue by Country (2016-2027)
- 11.3.3 Turkey
- 11.3.4 Saudi Arabia
- 11.3.5 U.A.E
12 Corporate Profiles
- 12.1 Thermo Fisher
- 12.1.1 Thermo Fisher Corporation Information
- 12.1.2 Thermo Fisher Overview
- 12.1.3 Thermo Fisher Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.1.4 Thermo Fisher Bovine Blood Plasma Derivatives Product Description
- 12.1.5 Thermo Fisher Related Developments
- 12.2 GE Healthcare
- 12.2.1 GE Healthcare Corporation Information
- 12.2.2 GE Healthcare Overview
- 12.2.3 GE Healthcare Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.2.4 GE Healthcare Bovine Blood Plasma Derivatives Product Description
- 12.2.5 GE Healthcare Related Developments
- 12.3 Merck (Sigma-Aldrich)
- 12.3.1 Merck (Sigma-Aldrich) Corporation Information
- 12.3.2 Merck (Sigma-Aldrich) Overview
- 12.3.3 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.3.4 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Product Description
- 12.3.5 Merck (Sigma-Aldrich) Related Developments
- 12.4 Moregate BioTech
- 12.4.1 Moregate BioTech Corporation Information
- 12.4.2 Moregate BioTech Overview
- 12.4.3 Moregate BioTech Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.4.4 Moregate BioTech Bovine Blood Plasma Derivatives Product Description
- 12.4.5 Moregate BioTech Related Developments
- 12.5 Gemini
- 12.5.1 Gemini Corporation Information
- 12.5.2 Gemini Overview
- 12.5.3 Gemini Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.5.4 Gemini Bovine Blood Plasma Derivatives Product Description
- 12.5.5 Gemini Related Developments
- 12.6 Atlanta Biologicals
- 12.6.1 Atlanta Biologicals Corporation Information
- 12.6.2 Atlanta Biologicals Overview
- 12.6.3 Atlanta Biologicals Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.6.4 Atlanta Biologicals Bovine Blood Plasma Derivatives Product Description
- 12.6.5 Atlanta Biologicals Related Developments
- 12.7 Tissue Culture Biologicals
- 12.7.1 Tissue Culture Biologicals Corporation Information
- 12.7.2 Tissue Culture Biologicals Overview
- 12.7.3 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.7.4 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Product Description
- 12.7.5 Tissue Culture Biologicals Related Developments
- 12.8 Bovogen
- 12.8.1 Bovogen Corporation Information
- 12.8.2 Bovogen Overview
- 12.8.3 Bovogen Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.8.4 Bovogen Bovine Blood Plasma Derivatives Product Description
- 12.8.5 Bovogen Related Developments
- 12.9 Biowest
- 12.9.1 Biowest Corporation Information
- 12.9.2 Biowest Overview
- 12.9.3 Biowest Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.9.4 Biowest Bovine Blood Plasma Derivatives Product Description
- 12.9.5 Biowest Related Developments
- 12.10 Internegocios
- 12.10.1 Internegocios Corporation Information
- 12.10.2 Internegocios Overview
- 12.10.3 Internegocios Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.10.4 Internegocios Bovine Blood Plasma Derivatives Product Description
- 12.10.5 Internegocios Related Developments
- 12.11 RMBIO
- 12.11.1 RMBIO Corporation Information
- 12.11.2 RMBIO Overview
- 12.11.3 RMBIO Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.11.4 RMBIO Bovine Blood Plasma Derivatives Product Description
- 12.11.5 RMBIO Related Developments
- 12.12 Biological Industries
- 12.12.1 Biological Industries Corporation Information
- 12.12.2 Biological Industries Overview
- 12.12.3 Biological Industries Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.12.4 Biological Industries Bovine Blood Plasma Derivatives Product Description
- 12.12.5 Biological Industries Related Developments
- 12.13 VWR
- 12.13.1 VWR Corporation Information
- 12.13.2 VWR Overview
- 12.13.3 VWR Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.13.4 VWR Bovine Blood Plasma Derivatives Product Description
- 12.13.5 VWR Related Developments
- 12.14 Corning
- 12.14.1 Corning Corporation Information
- 12.14.2 Corning Overview
- 12.14.3 Corning Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.14.4 Corning Bovine Blood Plasma Derivatives Product Description
- 12.14.5 Corning Related Developments
- 12.15 Serana
- 12.15.1 Serana Corporation Information
- 12.15.2 Serana Overview
- 12.15.3 Serana Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.15.4 Serana Bovine Blood Plasma Derivatives Product Description
- 12.15.5 Serana Related Developments
- 12.16 Lanzhou Minhai
- 12.16.1 Lanzhou Minhai Corporation Information
- 12.16.2 Lanzhou Minhai Overview
- 12.16.3 Lanzhou Minhai Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.16.4 Lanzhou Minhai Bovine Blood Plasma Derivatives Product Description
- 12.16.5 Lanzhou Minhai Related Developments
- 12.17 Zhejiang Tianhang Biotechnology
- 12.17.1 Zhejiang Tianhang Biotechnology Corporation Information
- 12.17.2 Zhejiang Tianhang Biotechnology Overview
- 12.17.3 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.17.4 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Product Description
- 12.17.5 Zhejiang Tianhang Biotechnology Related Developments
- 12.18 ExCell Bio
- 12.18.1 ExCell Bio Corporation Information
- 12.18.2 ExCell Bio Overview
- 12.18.3 ExCell Bio Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.18.4 ExCell Bio Bovine Blood Plasma Derivatives Product Description
- 12.18.5 ExCell Bio Related Developments
- 12.19 Jin Yuan Kang
- 12.19.1 Jin Yuan Kang Corporation Information
- 12.19.2 Jin Yuan Kang Overview
- 12.19.3 Jin Yuan Kang Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.19.4 Jin Yuan Kang Bovine Blood Plasma Derivatives Product Description
- 12.19.5 Jin Yuan Kang Related Developments
- 12.20 American Protein Company
- 12.20.1 American Protein Company Corporation Information
- 12.20.2 American Protein Company Overview
- 12.20.3 American Protein Company Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.20.4 American Protein Company Bovine Blood Plasma Derivatives Product Description
- 12.20.5 American Protein Company Related Developments
- 8.21 Sonac
- 12.21.1 Sonac Corporation Information
- 12.21.2 Sonac Overview
- 12.21.3 Sonac Bovine Blood Plasma Derivatives Sales, Price, Revenue and Gross Margin (2016-2021)
- 12.21.4 Sonac Bovine Blood Plasma Derivatives Product Description
- 12.21.5 Sonac Related Developments
13 Industry Chain and Sales Channels Analysis
- 13.1 Bovine Blood Plasma Derivatives Industry Chain Analysis
- 13.2 Bovine Blood Plasma Derivatives Key Raw Materials
- 13.2.1 Key Raw Materials
- 13.2.2 Raw Materials Key Suppliers
- 13.3 Bovine Blood Plasma Derivatives Production Mode & Process
- 13.4 Bovine Blood Plasma Derivatives Sales and Marketing
- 13.4.1 Bovine Blood Plasma Derivatives Sales Channels
- 13.4.2 Bovine Blood Plasma Derivatives Distributors
- 13.5 Bovine Blood Plasma Derivatives Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
- 14.1 Bovine Blood Plasma Derivatives Industry Trends
- 14.2 Bovine Blood Plasma Derivatives Market Drivers
- 14.3 Bovine Blood Plasma Derivatives Market Challenges
- 14.4 Bovine Blood Plasma Derivatives Market Restraints
15 Key Finding in The Global Bovine Blood Plasma Derivatives Study
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on Bovine Blood Plasma Derivatives . Industry analysis & Market Report on Bovine Blood Plasma Derivatives is a syndicated market report, published as Global Bovine Blood Plasma Derivatives Market Insights and Forecast to 2027. It is complete Research Study and Industry Analysis of Bovine Blood Plasma Derivatives market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
